Stewardship Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Buy
264
+18
+7% +$18.4K 0.07% 136
2026
Q1
$226K Sell
246
-23
-9% -$23.3K 0.05% 152
2025
Q4
$289K Buy
+269
New +$257K 0.07% 119

Other funds holding LLY

Stewardship Advisors's LLY Position: Q2 2026 in Review

Stewardship Advisors increased its Eli Lilly (LLY) stake by 7.3% in Q2 2026, buying an estimated $18.4K and bringing the position to 264 shares worth $317K. The position accounts for 0.07% of the portfolio, ranked #136.

Stewardship Advisors first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,211 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Stewardship Advisors held 264 shares of Eli Lilly worth $317K as of Q2 2026.
  • Stewardship Advisors bought 18 Eli Lilly shares in Q2 2026, an estimated $18.4K.
  • Eli Lilly made up 0.07% of Stewardship Advisors's portfolio in Q2 2026, its #136 holding.
  • Stewardship Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,211 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Stewardship Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.